| Identification | More | [Name]
2,4-Dimethylbenzenesulfonyl chloride | [CAS]
609-60-9 | [Synonyms]
2,4-DIMETHYLBENZENESULFONYL CHLORIDE
AKOS B019390
AKOS BBS-00000860
ART-CHEM-BB B019390
CHEMBRDG-BB 4009794
2,4-dimethyl-benzenesulfonylchlorid
2,4-Dimethylbenzene-1-sulfonyl chloride
2,4-Dimethyl-1-benzenesulfonyl chloride | [Molecular Formula]
C8H9ClO2S | [MDL Number]
MFCD00156143 | [Molecular Weight]
204.67 | [MOL File]
609-60-9.mol |
| Chemical Properties | Back Directory | [Melting point ]
28-33 °C | [Boiling point ]
82°C/0.4mm | [density ]
1.290±0.06 g/cm3(Predicted) | [Fp ]
>110°(230°F) | [refractive index ]
1.5550 | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [solubility ]
Chloroform (Slightly), Ethyl Acetate (Slightly) | [form ]
Solid | [color ]
Off-White | [Sensitive ]
Moisture Sensitive | [InChI]
1S/C8H9ClO2S/c1-6-3-4-8(7(2)5-6)12(9,10)11/h3-5H,1-2H3 | [InChIKey]
FREOGXBZEAMJQN-UHFFFAOYSA-N | [SMILES]
Cc1ccc(c(C)c1)S(Cl)(=O)=O | [CAS DataBase Reference]
609-60-9(CAS DataBase Reference) | [EPA Substance Registry System]
609-60-9(EPA Substance) |
| Safety Data | Back Directory | [Hazard Codes ]
C | [Risk Statements ]
R34:Causes burns. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . | [RIDADR ]
3261 | [WGK Germany ]
1 | [TSCA ]
T | [HazardClass ]
8 | [PackingGroup ]
II | [HS Code ]
2930909899 | [Storage Class]
8A - Combustible corrosive hazardous materials | [Hazard Classifications]
Skin Corr. 1B |
| Hazard Information | Back Directory | [Uses]
2,4-Dimethylbenzenesulfonyl Chloride is used as a reagent in the synthesis of dimethyl benzimidazolones as potent and selective inhibitors of BRPF1 bromodomain. 2,4-Dimethylbenzenesulfonyl Chloride is also used as a reagent in the synthesis of quinazoline analogs as glucocerebrosidase inhibitors with chaperone activity for the treatment of Gaucher disease. |
|
|